Inhibitors of p56 lck : assessing their potential as tools for manipulating T-lymphocyte activation

J Dowden, S G Ward

Research output: Contribution to journalArticle

12 Citations (Scopus)
Original languageEnglish
Pages (from-to)295-306
Number of pages12
JournalExpert Opinion on Therapeutic Patents
Volume11
Issue number2
Publication statusPublished - 2001

Cite this

Inhibitors of p56 lck : assessing their potential as tools for manipulating T-lymphocyte activation. / Dowden, J; Ward, S G.

In: Expert Opinion on Therapeutic Patents, Vol. 11, No. 2, 2001, p. 295-306.

Research output: Contribution to journalArticle

@article{f9e65b9a1172453cae8568356c6ac7db,
title = "Inhibitors of p56 lck : assessing their potential as tools for manipulating T-lymphocyte activation",
author = "J Dowden and Ward, {S G}",
year = "2001",
language = "English",
volume = "11",
pages = "295--306",
journal = "Expert Opinion on Therapeutic Patents",
issn = "1354-3776",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Inhibitors of p56 lck : assessing their potential as tools for manipulating T-lymphocyte activation

AU - Dowden, J

AU - Ward, S G

PY - 2001

Y1 - 2001

M3 - Article

VL - 11

SP - 295

EP - 306

JO - Expert Opinion on Therapeutic Patents

JF - Expert Opinion on Therapeutic Patents

SN - 1354-3776

IS - 2

ER -